Seeing is Believing: The Growth of the Medical Membranes Market

The medical membranes are widely used in the healthcare, pharmaceutical, biotechnology, and life science industries. It is one of the important application areas as the choice of the membrane for this application depends on a number of factors. These factors include environments of the proposed application, degree of sterility required, chemical compatibility, biocompatibility, degree of hydrophobicity, device fabrication, and sterilization.

Link to Download PDF Brochure http://www.marketsandmarkets.com/pdfdownload.asp?id=86

Medical membrane can be divided on the basis of their chemistry that are polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), polyethylene (PE), modified acrylics, and others. PTFE is an inert material that has good flow properties with high chemical resistance. PVDF is also a durable material with good flow properties and broad chemical resistance. PE is a material with excellent flow properties and broad chemical resistance. Based on the filtration technology, medical membranes can be divided into the following, ultrafiltration, microfiltration, reverse osmosis &dialysis, nanofiltration, and others.

The demand of medical membranes is projected to register higher growth for the hemodialysis application. Other major applications include infusion filters & sterile filtration and drug delivery. Currently, 347 Million people globally have diabetes. The diabetic population is projected to grow to 440 Million by 2030. India has the major share of the diabetes population with over 51 Million people having diabetes, followed by China with more than 43 million diabetic people. These people require hemodialysis.

Companies such as Asahi Kasei Co. (Japan), Hyflux Ltd. (Singapore), Koch Membranes System (U.S.), Merck Millipore (Canada), Pall Corporation (U.S.), 3M Company (U.S.), and others are the dominant market players in the global medical membranes market.

The Medical Membranes Market is projected to be worth USD 7.4 Billion by 2020, registering a CAGR of 9.9% between 2015 and 2020.

Get Report Sample 

Growth in biopharmaceuticals and new therapeutics markets is leading the growth of this market in North America and Europe

Membranes are used in the medical industry to meet the increased demand of high purity components. Membranes offer high selectivity and permeability, thus providing additional advantage. The drivers of the medical membranes market in North America and Europe are the rising cost of product development and manufacturing, pharmaceutical price control and competition with generics, more severe clinical trial hurdles, and more stringent environmental regulations.

Germany is the largest market for medical membranes in Europe that is projected to register significant growth between 2015 and 2020. The U.S. is the largest market for medical membranes in North America and it is projected to witness a high growth between 2015 and 2020.

Increasing incidents of diabetes and end-stage renal disease (ESRD) in developing regions such as Asia-Pacific and RoW

The incidents of diabetes and end-stage renal disease (ESRD) are increasing due to the rise in the aging population and the increase in the number of obese people. With this rise, the healthcare, pharmaceutical, and biotechnology industries are also witnessing significant growth in countries such as India and China. India has the world’s largest number of diabetic population and China has the world’s second-largest number of diabetic population. The medical membranes market is projected to register high growth in the Middle East & Africa and Latin America in the next five years due to increased rates of diabetes and advancement of the healthcare market.